Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

5.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
5.0K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.9K
2.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

9.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.5K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

5.8K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.8K
The Ras Gene02:38

The Ras Gene

7.6K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.6K
Abnormal Proliferation02:23

Abnormal Proliferation

5.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-invasive profiling of the tumour microenvironment with spatial ecotypes.

Nature·2026
Same author

Bridging the gap: A systematic approach to integrating serum and plasma proteomic datasets for biomarker studies.

Journal of pharmaceutical and biomedical analysis·2026
Same author

Clonal determinants of organotropism and survival in metastatic uveal melanoma.

NPJ precision oncology·2026
Same author

LZTR1 is a melanoma oncogene that promotes invasion and suppresses apoptosis.

Oncogene·2025
Same author

The ERVK3-1 Microprotein Interacts with the HUSH Complex.

Biochemistry·2025
Same author

Blocking Nitrosylation Induces Immunogenic Cell Death by Sensitizing NRAS-Mutant Melanoma to MEK Inhibitors.

Cancer research·2025

Related Experiment Video

Updated: Apr 20, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K

RAC1 and melanoma.

Ruth Halaban1

  • 1Yale University School of Medicine, Department of Dermatology, New Haven, Connecticut.

Clinical Therapeutics
|December 4, 2014
PubMed
Summary

The RAC1(P29S) mutation drives melanoma by promoting cell growth and migration. Activated RAC1, even without this mutation, presents a promising therapeutic target for melanoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • RAC1 is a GTPase in the RAS superfamily.
  • The RAC1(P29S) mutation is the third most common recurrent mutation in melanomas, found in 4-7% of patients.
  • This mutation results in a constitutively active GTP-bound RAC1 protein, enhancing melanocyte proliferation and migration.

Purpose of the Study:

  • To review the functional role of RAC1(P29S) in melanoma.
  • To explore RAC1 as a therapeutic target in melanoma, irrespective of mutation status.
  • To investigate RAC1's role in drug resistance to BRAF and MEK inhibitors.

Main Methods:

  • Literature review and data synthesis.
  • Analysis of existing data on RAC1 activation in melanoma.
Keywords:
Hotspot mutationdrug resistancemigrationproliferation

More Related Videos

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
10:23

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

14.3K
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

18.9K

Related Experiment Videos

Last Updated: Apr 20, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K
Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
10:23

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

14.3K
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

18.9K
  • Discussion of therapeutic implications.

    • Main Results:

    • Ectopic expression of RAC1(P29S) increases melanocyte proliferation and migration.
    • Evidence suggests RAC1 is activated in melanoma cells lacking the RAC1(P29S) mutation.
    • The role of RAC1 in conferring resistance to BRAF or MEK inhibitors remains unclear.

    Conclusions:

    • Activated RAC1 is a potential therapeutic target in melanoma.
    • Further research is needed to clarify RAC1's role in drug resistance mechanisms.